Showing all 5 results
Myocardial Infarction Leukopak
LeukoCore™ Myocardial Infarction Leukopak products contain concentrated immune cells from donors with clinically confirmed myocardial infarction (MI), collected via apheresis. Ideal for high-yield studies on post-infarction inflammation, immune-mediated cardiac repair, and biomarker discovery in ischemic heart disease.
Myocardial Infarction PBMC
Myocardial Infarction PBMC samples are isolated from donors with clinically confirmed myocardial infarction (MI). Ideal for studying immune cell responses, post-infarction inflammation, and cellular mechanisms involved in cardiac repair and remodeling.
Myocardial Infarction Plasma
Myocardial Infarction Plasma samples are collected from donors diagnosed with myocardial infarction (MI). Suitable for profiling cardiac injury biomarkers such as troponin, NT-proBNP, and inflammatory cytokines associated with acute coronary events and ischemic damage.
Myocardial Infarction Serum
Myocardial Infarction Serum samples are derived from donors with confirmed myocardial infarction (MI). Useful for analyzing cardiac enzymes, lipid panels, and systemic markers of inflammation and oxidative stress following infarction.
Myocardial Infarction Whole Blood
Myocardial Infarction Whole Blood samples are obtained from donors with clinically diagnosed myocardial infarction (MI). Valuable for transcriptomic studies, immune profiling, and evaluating genetic and molecular contributors to atherosclerosis and cardiac injury.